 | Up a level |
Bräutigam, Konstantin; Chouchane, Aziz; Konukiewitz, Björn; Perren, Aurel (2024). [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls]. Pathologie, 45(1), pp. 35-41. Springer 10.1007/s00292-023-01276-4
Jesinghaus, Moritz; Steiger, Katja; Slotta-Huspenina, Julia; Drecoll, Enken; Pfarr, Nicole; Meyer, Petra; Konukiewitz, Björn; Bettstetter, Marcus; Wieczorek, Kathrin; Ott, Katja; Feith, Markus; Langer, Rupert; Weichert, Wilko; Specht, Katja; Boxberg, Melanie (2017). Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. OncoTarget, 8(29), pp. 46756-46768. Impact Journals LLC 10.18632/oncotarget.18606
Agaimy, Abbas; Erlenbach-Wünsch, Katharina; Konukiewitz, Björn; Schmitt Kurrer, Anja; Rieker, Ralf J.; Vieth, Michael; Kiesewetter, Franklin; Hartmann, Arndt; Zamboni, Giuseppe; Perren, Aurel; Klöppel, Günter (2013). ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Modern pathology, 26(7), pp. 995-1003. Nature Publishing Group 10.1038/modpathol.2013.40
Hermann, Gratiana; Konukiewitz, Björn; Schmitt, Anja; Perren, Aurel; Klöppel, Günter (2011). Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2. Virchows Archiv, 459(2), pp. 147-54. Berlin: Springer 10.1007/s00428-011-1118-6
